Dapagliflozin plus Saxagliptin Add-On to Metformin Reduces Liver Fat and Adipose Tissue Volume in Patients with Type 2 Diabetes

被引：0
|
作者：
Wilding, John P.
Hockings, Paul
Johnsson, Eva K.
Maaske, Jill
Garcia-Sanchez, Ricardo
Johansson, Lars
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-1175-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Dapagliflozin plus saxagliptin add-on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetes
    Johanssoni, I.
    Hockings, P.
    Johnsson, E. K.
    Maaskes, J.
    Garcia-Sanchez, R.
    Wilding, J. P.
    [J]. DIABETOLOGIA, 2018, 61 : S314 - S314
  • [2] Dapagliflozin plus saxagliptin add-on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetes
    Johansson, Lars
    Hockings, Paul D.
    Johnsson, Eva
    Dronamraju, Nalina
    Maaske, Jill
    Garcia-Sanchez, Ricardo
    Wilding, John P. H.
    [J]. DIABETES OBESITY & METABOLISM, 2020, 22 (07): : 1094 - 1101
  • [3] DAPAGLIFLOZIN PLUS SAXAGLIPTIN ADD-ON TO METFORMIN MAINTAINS REDUCED LIVER FAT AND ADIPOSE TISSUE VOLUMES IN PATIENTS WITH TYPE 2 DIABETES OVER 122 WEEKS
    Johansson, Lars
    Hockings, Paul
    Frias, Juan P.
    Suchower, Lisa
    Maaske, Jill
    Iqbal, Nayyar
    Wilding, John P. H.
    [J]. HEPATOLOGY, 2020, 72 : 1048 - 1048
  • [4] Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetes
    Mueller-Wieland, Dirk
    Kellerer, Monika
    Cypryk, Katarzyna
    Skripova, Dasa
    Rohwedder, Katja
    Johnsson, Eva
    Garcia-Sanchez, Ricardo
    Kurlyandskaya, Raisa
    Sjostrom, C. David
    Jacob, Stephan
    Seufert, Jochen
    Dronamraju, Nalina
    Csomos, Katalin
    [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (11): : 2598 - 2607
  • [5] Dapagliflozin plus Saxagliptin Add-On vs. Glimepiride Add-On to Metformin in Patients with Poorly Controlled Type 2 Diabetes
    Frias, Juan P.
    Gonzalez-Galvez, Guillermo
    Johnsson, Eva K.
    Maaske, Jill
    Peters, Anne
    [J]. DIABETES, 2018, 67
  • [6] Randomised, double-blind trial of dual add-on saxagliptin plus dapagliflozin vs saxagliptin or dapagliflozin add-on alone in poorly controlled type 2 diabetes on metformin
    Hansen, L.
    Zee, P.
    Li, Y.
    Cook, W.
    Hirshberg, B.
    Iqbal, N.
    Rosenstock, J.
    [J]. DIABETOLOGIA, 2014, 57 : S8 - S8
  • [7] Dapagliflozin versus saxagliptin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin
    Rosenstock, Julio
    Mathieu, Chantal
    Chen, Hungta
    Garcia-Sanchez, Ricardo
    Saraiva, Gabriela Luporini
    [J]. ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2018, 62 (04): : 424 - 430
  • [8] Dapagliflozin plus saxagliptin plus metformin triple therapy vs sitagliptin add-on to metformin dual therapy in subgroups of patients with uncontrolled type 2 diabetes
    Del Prato, S.
    Handelsman, Y.
    Mathieu, C.
    Johnsson, E.
    Kurlyandskaya, R.
    Iqbal, N.
    Garcia-Sanchez, R.
    Rosenstock, J.
    [J]. DIABETOLOGIA, 2017, 60 : S20 - S21
  • [9] Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-on to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes
    Matthaei, Stephan
    Catrinoiu, Doina
    Celinski, Aleksander
    Ekholm, Ella
    Cook, William
    Hirshberg, Boaz
    Chen, Hungta
    Iqbal, Nayyar
    Hansen, Lars
    [J]. DIABETES CARE, 2015, 38 (11) : 2018 - 2024
  • [10] Efficacy and safety of triple therapy with dapagliflozin add-on to saxagliptin plus metformin over 52 weeks in patients with type 2 diabetes
    Mathieu, C.
    Herrera Marmolejo, M.
    Gonzalez Gonzalez, J. G.
    Hansen, L.
    Chen, H.
    Johnsson, E.
    Garcia-Sanchez, R.
    Iqbal, N.
    [J]. DIABETES OBESITY & METABOLISM, 2016, 18 (11): : 1134 - 1137
12345